TRPV2 and myeloid sarcoma: Therefore, this downregulation could be interpreted as the result of cell death observed in MS patients [50,51], or as the failure of oligodendrocytes to promote remyelination, thus approaching a scenario—with their respective important and characteristic pathological differences—similar to that observed in TRPV2 expression in the chronic inflammation of jimpy mice.